By Ludwig Burger (Reuters) -Roche agreed to take over unlisted obesity drug developer Carmot Therapeutics for $2.7 billion upfront, joining a list of contestants seeking to...
Quiver Quantitative - Swiss pharmaceutical giant Roche (ROG) has marked a significant strategic shift by acquiring Carmot Therapeutics (CRMO), an obesity drug developer, for an...
Investing.com — Here is your Pro Recap of 5 head-turning deal dispatches you may have missed last week: Chevron to buy Hess for $53 billion, Vista Equity Partners to pick up...
(Reuters) -Royalty Pharma said on Thursday it has purchased additional royalties on Roche and PTC Therapeutics (NASDAQ:PTCT)' oral spinal muscular atrophy (SMA) drug for an...
Swiss pharmaceutical giant Roche Holding AG (OTC:RHHVF) has seen a 6% decrease in sales for the first three quarters of this year, a slump that has triggered a 3.2% drop in shares....
By Sruthi Shankar and Shashwat Chauhan (Reuters) -European shares fell on Tuesday as weak services sector data from China and the euro zone fuelled concerns about slowing global...
By Ankika Biswas and Shashwat Chauhan (Reuters) -European shares closed off their day's highs on Wednesday on growing evidences of slowing economic activity in the continent,...
18 per and 4% dividend starts looking good. Long hold and nice life investment in one of Europe best companies in a non hype sector
0
What happened today?
1
It is a buy at 266
2
When ist best time to buy?
0
SP suffering since May 2022 due to decline in COVID vaccines.
0
macd indicators showing a nice jump coming, keeping my fingers crossed during these dark times
0
What happened today?
0
The SKYSCRAPER-01 study evaluating tiragolumab plus Tecentriq did not meet its co-primary endpoint of progression-free survival
0
Today only this info about Roche
0
A large pharmaceutical company, by the name of R. , is pushing down the value of the Spanish company's Pharmamar share price through the funds Consonance Capital and Great Point Partners, so that the biotech company accepts its offer of more than 4500 million dollars.According to this pharma, Pharmamar's products have a great future in oncology and virology, and would be fully engaged in its search for new drugs.
5
hello to Marinopoulos Pharma company .!
0
Trades ex dividend!!
0
Currently near to Fibo 61.8 levels, a great company to buy IMO.